ReviewFrontiers in neuroscience2025
Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair.
Review in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Liver-nervous system axis: pathways, dysregulation, and translational perspectives.Journal of neuroinflammation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the central nervous system, astrocytes are highly specialized non-neuronal cells that are key elements in maintaining neuronal microenvironment homeostasis. These cells provide structural and metabolic support to other brain cells and regulate ion concentrations and the local levels of neurotransmitters such as glutamate. Astrogliosis, characterized by morphological and functional abnormalities, has been implicated in various neuronal disorders. Similarly, hepatic stellate cells drive the initiation and the progression of liver fibrosis. After liver injury, hepatic stellate cells are activated through inflammatory mediators and differentiate into activated myofibroblasts. Hepatic stellate cells express several glial-related molecules, suggesting functional similarities between these two cell types, which paves the way for a better understanding of crucial targets for neuronal and liver repair. We present herein a compressive update of our current knowledge of the transcriptome of activated hepatic stellate cells during liver injury and contrast it with that of reactive astrocytes in neuronal diseases. Furthermore, we summarize the plausible involvement of long non-coding and microRNAs in the transcriptional regulation of specific genes during neuronal and liver injuries. Finally, we discuss possible common targets and novel strategies to diminish the activation of stellate cells and astrocytes as therapeutic strategies. In addition, we highlight new insights into the brain-liver axis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.